Effect of sodium butyrate on human breast cancer cell lines

Cell Proliferation

Volumn 30, Issue 3-4, 1997, Pages 149-159

  Coradini, D ^a   Biffi, A ^a   Costa, A ^a   Pellizzaro, C ^a   Pirronello, E ^a   Di Fronzo, G ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; DNA FRAGMENT; STEROID RECEPTOR;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER THERAPY; CELL CYCLE; CELL CYCLE G2 PHASE; CELL GROWTH; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOSIS;

EID: 0030785434     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2184.1997.tb00931.x     Document Type: Article

References (36)

1. BARNARD JA, WARWICK G. (1993) Butyrate rapidly induces growth inhibition and differentiation in HT29 cells. Cell Growth Diff. 4, 495.
2. BOFFA LC, VIDALI G, MANN RS, ALFREY VG. (1978) Suppression of historic deacetylation in vivo and in vitro by sodium butyrate. J. Biok. Chem. 253, 3364.
3. BURTON DA. (1956) Studies of conditions and mechanism of the diphenylamine reaction for the colorimetric determination of deoxyribonucleic acid. Biochem. J. 62, 315.
4. CAILLEAU R, YOUNG R, OLIVE M. (1974) Breast tumor cell lines from pleural effusion. J. Natl. Cancer Inst. 53, 661.
5. CALABRESSE C, VENTURINI L, RONCO G, VILLA P, CHOMIENNE C, BELPOMME D. (1993) Butyric acid and its monosaccharide ester induce apoptosis in the HL60 cell line. Biochem. Bioph. Res. Comm. 195, 31.
6. CANDIDO EPM, REEVES R, DAVIE RD. (1978) Sodium butyrate inhibits histone deacetylation in culture cell. Cell 14, 105.
7. COLLINS SJ, RUSCETTI FW, GALLAGHER RE, CALLO RC. (1978) Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA 75, 2458.
8. COLOTTA F, POLENTARUTTI N, SIRANI M, MANTOVANI A. (1992) Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J. Biol. Chem. 267, 18278.
9. D'ANNA JA, TOBEY RA, GURLEY LR. (1990) Concentration-dependent effects of sodium butyrate in Chinese hamster cells: cell-cycle progression, inner-histone acetylation, histone H1 dephosphorylation and induction of an H1-like protein. Biochem. 19, 2656.
10. DANO GV. (1991) c-myc oncoprotein function. Biochem. Biophys. Acta 1072, 103.
11. FALLON RJ, COX RP. (1979) Cell cycle analysis of sodium butyrate and hydroxurea inducers of ectopic hormone production in HeLa cells. J. Cell. Physiol. 100, 251.
12. FENG P, GE L, AKYHANI N, LIAU G. (1996) Sodium butyrate is a potent modulator of smooth muscle cell proliferation and gene expression. Cell Prolif. 29, 231.
13. FRANGOS DN, KILLION JJ, FAN D, FISHERBECK R, ESCHENBACH AC, FIDLER IJ. (1990) The development of liposomes containing interferon alpha for the intravesical therapy of human superficial bladder cancer. J. Urol. 143, 1252.
14. GUILBAUD NF, GAS N, DUPONT MA, VALETTE A. (1990) Effects of differentiation-inducing agents on maturation of human MCF7 breast cancer cells. J. Cell. Physiol. 145, 162.
15. KEYDAR I, CHEN L, KARBY S. (1979) Establishment and characterization of a cell line of a human breast carcinoma. Eur. J. Cancer 15, 659.
16. LANGDON SP, HAWKES MM, HAY FG et al. (1988) Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines. Cancer Res. 48, 6161.
17. LASFARGUES EY, OZZELLO L. (1958) Cultivation of human breast carcinoma. J. Natl. Cancer Inst. 21, 1131.
18. LEDER A, LEDER P. (1975) Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemia cells. Cell 5, 319.
19. MANDAL M, KUMAR R. (1996) Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF7 breast cancer cells. Cell Growth Diff. 7, 311.
20. MARINI M, MUSIANI D, SESTILI P, CANTONI O. (1996) Apoptosis of human lymphocytes in the absence or presence of intranucleosomal DNA cleavage. Biochem. Biophys. Res. Comm. 229, 910.
21. MILLER A, KURSCHEL E, SCHMIDT CG, OSIEKA R. (1985) Clinical and pharmacological study of sodium butyrate in patients with acute leukemia. Proc. Am. Assoc. Cancer Res. 26, 1046.
22. MILLER A, KURSCHEL E, OSIEKA A, SCHMIDT CG. (1987) Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur. J. Clin. Oncol. 28, 1283.
23. NOVOGRODSKY A, DVIR A, RAVID A et al. (1983) Effect of polar organic compounds on leukemic cells: butyrate-induced partial remission of acute myelogenous leukemia in a child. Cancer 51, 9.
24. OWEN RR, SELLS RA, GILMORE IT, NEW RRC, STRINGER RE. (1992) A phase I clinical evaluation of liposome-entrapped doxorubicin (Lip-Dox) in patients with primary and metastatic hepatic malignancy. Anti-Cancer Drugs 3, 101.
25. PLANCHON P, RAUX H, MAGNIEN U et al. (1991) New stable butyrate derivatives alter proliferation and differentiation in human mammary cells. Int. J. Cancer 48, 443.
26. POUILLART P, CERUTI I, RONCO G, VILLA P, CHANY C. (1991) Butyric monosaccharide ester induced cell differentiation and anti-tumor activity in mice. Importance of their prolonged biological effect for clinical applications in cancer therapy. Int. J. Cancer 49, 89.
27. PRASAD KN. (1990) Butyric acid: a small fatty acid with diverse biological functions. Life Sci. 27, 1351.
28. RAPHAELI A, RABIZADEH E, AVIRAM A, SHAKLAI M, RUSE M, NUDELMAN A. (1991) Derivatives of butyric acid as potential anti-neoplastic agents. Int. J. Cancer 49, 66.
29. RONOT X, HECQUET C, LARNO S. (1986) G2 arrest binucleation and single-parameter DNA flow cytometric analysis. Cytometry 7, 286.
30. SEALY L, CHALKLEY R. (1978) The effect of sodium butyrate on histone modification. Cell 14, 115.
31. Soule HD, Vazques J, Long A. (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51, 1409.
32. STAIANO-COICO L, HIGGINS PJ. (1990) Epidermal cell-shape regulation and subpopulation kinetics during butyrate-induced terminal maturation of normal and SV40-transformed human keratinocytes: epithelial models of differentiation therapy. Int. J. Cancer 46, 733.
33. STEVENS MS, ALIABADI Z, MOORE MR. (1984) Associated effects of sodium butyrate on histone acetylation and estrogen receptor in human breast cancer cell line MCF7. Biochem. Biophys. Res. Comm. 119, 132.
34. STORM G, WILM HP, CROMMELIN DJA. (1991) Liposomes and biotherapeutics. Biotherapy 3, 25.
35. TSAO D, MORITA A, BELLA A, LIU P, KIM YS. (1982) Differential effects of sodium butyrate dimethyl sulfoxide and retinoic acid on membrane-associated antigen, enzymes and glycoproteins of human rectal adenocarcinoma cells. Cancer Res. 42, 1052.
36. TSAO D, SHI Z, WONG A, KIM YS. (1983) Effect of sodium butyrate on carcinoembryonic cells in culture. Cancer Res. 43, 1217.